The medical technology investor SHS has acquired a 24.9% stake in Blazejewski MEDI-TECH GmbH, a leading manufacturer of endoscopes. This minority investment aims to promote internationalization, boost sales, and bring new endoscopy products to market maturity. Blazejewski MEDI-TECH develops and produces high-quality 2D and 3D endoscopes for minimally invasive surgery and robotics.
Tübingen-based medical technology and life sciences investor SHS Gesellschaft für Beteiligungsmanagement has acquired a 24.9% stake in the Baden-based endoscope specialist Blazejewski MEDI-TECH GmbH. With SHS's minority investment, Blazejewski MEDI-TECH plans to strategically enhance sales, internationalize operations, and advance the development of new endoscopy products to market readiness.
Minimally invasive surgery (MIS) is the global standard for surgical and diagnostic procedures. This keyhole therapy, which undergoes continuous technical advancement, relies on high-quality endoscopy devices. The global market for endoscopy devices is around USD 9 billion, growing at approximately 9% annually.
Blazejewski MEDI-TECH GmbH is a leading manufacturer of medical endoscopes, renowned for its rigid and semi-rigid 2D endoscopes. Founded in 1991 by Reinhold Blazejewski, the company employs 70 people who develop and produce 2D and 3D endoscopes in Sexau, near Freiburg, Germany. Approval for 3D endoscopes of the BMTvision® type is planned for 2020. As an OEM, Blazejewski supplies global market leaders in medical technology.
Blazejewski MEDI-TECH GmbH, based in Sexau, Germany, was founded in 1991 by Reinhold Blazejewski. The company employs 70 people, with a quarter dedicated to R&D. They develop, produce, and sell medical endoscopes used in operating theaters worldwide. The product range includes rigid and flexible 2D endoscopes (including chip-on-the-tip technology) known for their excellent image quality. Additionally, Blazejewski offers 3D endoscopes, which provide exceptional spatial imaging and are unique worldwide with an outer diameter of less than 2.5 millimeters. The production of 3D endoscopes is a unique selling point. Blazejewski's 3D optics are also utilized in robotics outside the medical field.
Based in Tübingen, SHS Gesellschaft für Beteiligungsmanagement mbH invests in medical technology and life sciences companies, focusing on expansion financing, shareholder changes, and succession situations. SHS takes both minority and majority stakes. Founded in 1993, SHS supports the growth of its portfolio companies through a cooperative network, assisting with new product launches, regulatory issues, and market entry. SHS funds are backed by professional pension funds, pension schemes, strategic investors, funds of funds, family offices, entrepreneurs, and the SHS management team. The AIFM-registered company can invest up to EUR 30 million, with larger volumes possible through a network of co-investors. SHS is currently investing from its fifth fund, which has received over EUR 130 million in capital commitments.
ConAlliance is a leading M&A advisory firm specializing in comprehensive support for company sales and acquisitions in the healthcare sector. Since its founding in 2011, ConAlliance has successfully completed over 100 mandates.
ConAlliance's expertise is entirely focused on corporate transactions within the healthcare sector. Core competencies include medical technology, medical devices, pharmaceuticals, nursing and hospital care, healthcare IT, and other manufacturing and service companies in the global healthcare industry. Healthcare real estate is also part of its extensive portfolio.
ConAlliance has successfully supported numerous corporate transactions in the endoscopy segment in recent years. For more information on corporate transactions and M&A consulting in the endoscopy segment, please contact ConAlliance.